JHJonathan Huntley

Jonathan Huntley

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jonathan Huntley has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Non-invasive Vagal Nerve Stimulation for Cognitive and Physical Impairment in Older Adults: A Systematic Scoping Review, Meta-Analysis, and Expert Consultation

    by Thomas Christopher Richards, Nathan Howarth, Clare Hammerton, Kim Chapman, Louise Allan, Jonathan D. Huntley, Michelle A. Miller, Selena P. Maxwell, Ivan Koychev, Kenneth Rockwood, et al.

    Background: Age-related cognitive and physical impairments contribute to loss of independence and healthcare burden. Non-invasive transcutaneous vagus nerve stimulation (tVNS) is a promising non-pharmacological intervention with potential effects across domains relevant to healthy ageing. We synthesised evidence for tVNS in older adults with cognitive or physical impairment and identified priorities for future trials. Methods: Five databases (MEDLINE, Embase, PsycINFO, CINAHL and Web of Science) were searched from inception to 10 March 2026. Primary studies investigating tVNS in older adults with or without cognitive or physical impairment were eligible. Study characteristics, stimulation protocols, outcomes, efficacy, safety and tolerability were synthesised, with random-effects meta-analysis where data were available. Findings were contextualised through consultation with people and carers with lived experience (n=19) and clinicians and researchers (n=12). Findings: Nineteen studies involving 1,159 participants were included, encompassing healthy ageing, cognitive impairment, neurological disease, mobility impairment and cardiometabolic conditions. Most used auricular tVNS, although stimulation protocols and outcome selection varied. No studies evaluated dose–response relationships, and 58 outcome measures were identified. Meta-analyses demonstrated significant effects for studies’ primary outcome(s) (Hedges' g=0·99, 95% CI 0·46–1·53, p0·05). Heterogeneity was substantial, and no study assessed whether benefits persisted. No major adverse effects attributable to tVNS were reported, although safety reporting was inconsistent. Interest-holders prioritised sleep, meaningful functional outcomes, and acceptable home-based delivery. Interpretation: Non-invasive tVNS shows proof-of-concept across outcomes relevant to healthy ageing, with the strongest pooled evidence for mood and sleep. Evidence for sustained cognitive or physical benefit remains insufficient, particularly for cognitive impairment and dementia. Future trials should establish target-specific stimulation protocols, combine clinically meaningful outcomes with mechanistic measures, and incorporate longer follow-up. Convergence between quantitative evidence and interest-holder priorities identified sleep as a promising target for future tVNS trials. Funding This review was funded by the NIHR HealthTech Research Centre Network Challenge Fund (Round 1, 2025). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. SPM is supported by a Canadian Institutes of Health Research (CIHR) Postdoctoral Fellowship Award (AGE-187960) and a Dalhousie University Department of Medicine University Internal Medicine Research Foundation Research Fellowship Award.

  • Open Access

    Synergistic and redundant information dynamics are modulated by Alzheimer's disease and cognitive impairment

    by Keenan J. A. Down, Jonathan Huntley, Pedro A. M. Mediano, Daniel Bor

    The early diagnosis of Alzheimer's disease (AD), a cause of progressive cognitive decline, remains challenging. Recent information-theoretic advances allow brain dynamics to be quantified in terms of how regions share and combine information. Integrated Information Decomposition (ΦID) separates redundant (the same content present in multiple regions) from synergistic information (new content that emerges only when regions are considered together). Such information-dynamic measures may provide biomarkers relevant to AD risk and progression. Here we applied integrated information decomposition (ΦID) to resting-state fMRI from the Alzheimer's Disease Neuroimaging Initiative (ADNI), to test whether ΦID measures are diagnostically sensitive and track cognition along the AD spectrum. For each region, we computed total synergy and redundancy and compared values across cognitively normal (CN), mild cognitive impairment (MCI), and AD groups. Compared to CN, AD patients showed a striking synergy reduction across the entire brain, in concert with widespread redundancy increases, particularly in the executive and default mode networks. Transitions from CN to AD included an intermediate MCI decrease in redundancy, possibly reflecting early disease compensation strategies. This AD informational shift from complex higher level information processing to more robust inefficient forms likely reflects a cognitive shift to simpler, less integrative cognitive processes. Indeed, when re-analysing the data according to a standard cognitive clinical test (the Montreal Cognitive Assessment), we found a synergy-redundancy shift in high versus low performers broadly very similar to the CN to AD shift. AD shows a clear information-processing signature: reduced global synergy and increased redundancy, especially in the executive control network. These striking results provide powerful insights into the widespread information processing reconfiguration that occurs in AD, with clear changes already emerging at the earlier MCI stage. Further, these results provide a novel route to support early diagnosis and stratification.

  • Open Access

    Neural markers of reduced arousal and consciousness in mild cognitive impairment

    by Mar Estarellas, Jonathan Huntley, Daniel Bor

    Objectives: People with Alzheimer's Disease (AD) experience changes in their level and content of consciousness, but there is little research on biomarkers of consciousness in pre‐clinical AD and Mild Cognitive Impairment (MCI). This study investigated whether levels of consciousness are decreased in people with MCI.Methods: A multi‐site site magnetoencephalography (MEG) dataset, BIOFIND, comprising 83 people with MCI and 83 age matched controls, was analysed. Arousal (and drowsiness) was assessed by computing the theta‐alpha ratio (TAR). The Lempel‐Ziv algorithm (LZ) was used to quantify the information content of brain activity, with higher LZ values indicating greater complexity and potentially a higher level of consciousness.Results: LZ was lower in the MCI group versus controls, indicating a reduced level of consciousness in MCI. TAR was higher in the MCI group versus controls, indicating a reduced level of arousal (i.e. increased drowsiness) in MCI. LZ was also found to be correlated with mini‐mental state examination (MMSE) scores, suggesting an association between cognitive impairment and level of consciousness in people with MCI.Conclusions: A decline in consciousness and arousal can be seen in MCI. As cognitive impairment worsens, measured by MMSE scores, levels of consciousness and arousal decrease. These findings highlight how monitoring consciousness using biomarkers could help understand and manage impairments found at the preclinical stages of AD. Further research is needed to explore markers of consciousness between people who progress from MCI to dementia and those who do not, and in people with moderate and severe AD, to promote person‐centred care.


  • Open Access

    Neural markers of reduced arousal and consciousness in Mild Cognitive Impairment

    by Mar Estarellas, Jonathan Huntley, Daniel Bor

    Objectives: People with Alzheimer’s Disease (AD) experience changes in their level and content of consciousness, but there is little research on biomarkers of consciousness in pre-clinical AD and MCI. This study investigated whether levels of consciousness are decreased in people with MCI. Methods: A multi-site MEG dataset, BIOFIND, comprising 83 people with MCI and 83 age matched controls, was analysed. Arousal (and drowsiness) was assessed by computing the theta-alpha ratio (TAR). The Lempel-Ziv algorithm (LZ) was used to quantify the information content of brain activity, with higher LZ values indicating greater complexity and potentially a higher level of consciousness. Results: LZ was lower in the MCI group vs controls, indicating a reduced level of consciousness in MCI. TAR was higher in the MCI group vs controls, indicating a reduced level of arousal (i.e. increased drowsiness) in MCI. LZ was also found to be correlated with MMSE scores, suggesting a direct link between cognitive impairment and level of consciousness in people with MCI. Conclusions: A decline in consciousness and arousal can be seen in MCI. As cognitive impairment worsens, measured by MMSE scores, levels of consciousness and arousal decrease. These findings highlight how monitoring consciousness using biomarkers could help understand and manage impairments found at the preclinical stages of AD. Further research is needed to explore markers of consciousness between people who progress from MCI to dementia and those who do not, and in people with moderate and severe AD, to promote person-centred care.

  • Open Access

    Assessing awareness in severe Alzheimer’s disease

    by Jonathan D Huntley, Daniel Bor, Adrian M Owen, Robert J Howard

    Background: There is an urgent need to understand the nature of awareness in severe AD to ensure effective person‐centred care. Transcranial Magnetic Stimulation (TMS) combined with Electroencephalography (EEG), Event Related Potentials (ERPs) and functional Magnetic Resonance Imaging (fMRI) are robust techniques for assessing awareness in clinical populations who are unable to communicate. We present novel feasibility and preliminary data on using these methods to assess capacity for consciousness and contents of awareness in severe AD.Method: a) TMS‐EEG was performed in 6 healthy older controls and 3 people with severe AD. The perturbational complexity index (PCIST) was calculated as a measure of capacity for conscious awareness. b) ERPs were recorded during a masked visual perception paradigm and analysed for the presence of visual awareness negativity and P400 components, previously identified as associated with conscious visual perception. c) An fMRI movie‐viewing task, validated in previous studies to demonstrate activation in a fronto‐parietal network during conscious engagement with the film was also conducted.Result: a) Participants with severe AD demonstrated a PCIST around the previously identified threshold for consciousness, suggesting reduced capacity for consciousness. b) In response to viewing faces, two patients with severe AD provisionally demonstrated similar visual awareness negativity to healthy controls. c) Healthy controls and one person with severe AD revealed spatially, but not temporally similar activation in a fronto‐parietal network, suggesting differences in conscious engagement with the movie.Conclusion: These biomarkers provide experimental approaches to assess awareness and improve understanding and care for people with severe AD.

  • Open Access

    Impact of the COVID‐19 pandemic on older adults mental health services: A mixed methods study

    by Rohan Bhome, Jonathan Huntley, Christian Dalton‐Locke, Norha Vera San Juan, Sian Oram, Una Foye, Gill Livingston

    The COVID-19 pandemic has had a significant impact on older adults mental health care. Our study aimed to explore staff perspectives on key challenges and innovations in order to help inform the delivery of older adults mental health care in subsequent waves of the pandemic. A mixed methods online questionnaire developed by National Institute for Health Research Mental Health Policy Research Unit was used to gather staff perspectives on their challenges at work, problems faced by service users and their carers, and sources of help and support. Descriptive statistics were used for quantitative analysis and descriptive content analysis for qualitative analysis. 158 participants, working in either community or inpatient settings, and from a range of professional disciplines, were included. For inpatient staff, a significant challenge was infection control. In the community, staff identified a lack of access to physical and social care as well as reduced contact with friends and families as being challenges for patients. Remote working was seen as a positive innovation along with COVID-19 related guidance from various sources and peer support. Our study, with a focus on staff and patient well-being, helps to inform service development for future waves of the pandemic. We discuss measures to improve infection control in inpatient settings, the role of voluntary organisations in supporting socially isolated community patients, the need for better integration of physical and mental health services at an organisational level, and the importance of training staff to support patients and their families with end of life planning.


  • Open Access

    A meta‐analysis of randomised controlled trials of physical activity in people with Alzheimer's disease and mild cognitive impairment with a comparison to donepezil

    by Sara Pisani, Christoph Mueller, Jonathan Huntley, Dag Aarsland, Matthew J. Kempton

    Objectives: Physical exercise may benefit people with Alzheimer's disease (AD) and mild cognitive impairment (MCI). However, randomised controlled trials (RCTs) of exercise have shown conflicting findings and it is unclear if positive outcomes are comparable to a commonly used cholinesterase inhibitor, donepezil.Methods: Embase, Medline, PsycINFO, PsycARTICLES, SCOPUS were searched for RCTs of physical activity compared to a control condition, and donepezil compared to placebo in people with AD and MCI. Effect sizes were calculated from pre‐ and post‐MMSE and ADAS‐Cog scores and pooled using a random effects meta‐analysis.Results: Ninteen RCTs were included in the exercise meta‐analysis (AD, N = 524; MCI, N = 1269). Physical exercise improved MMSE scores in AD (Hedges' g = 0.46) and MCI groups (g = 0.63). For the MCI group, exercise appeared to have a stronger effect for those with lower MMSE scores at baseline (p = 0.022). 18 RCTs were included in the donepezil meta‐analysis (AD, N = 2984, MCI, N = 1559). In people with AD, donepezil improved cognition (MMSE g = 0.23; ADAS‐Cog, g = −0.17) but there was no evidence of improved cognition in MCI.Conclusions: Physical exercise improved cognition in both AD and MCI groups. Where comparisons were possible, the effect size for physical exercise was generally comparable to donepezil. These results strengthen the evidence base for exercise as an effective intervention in AD and MCI, and future clinical trials should examine exercise type, intensity and frequency, in addition to cholinesterase inhibitors to determine the most effective interventions for AD and MCI.


  • Open Access

    “Falling through the cracks”; Stakeholders' views around the concept and diagnosis of mild cognitive impairment and their understanding of dementia prevention

    by Michaela Poppe, Hassan Mansour, Penny Rapaport, Marina Palomo, Alexandra Burton, Sarah Morgan‐Trimmer, Christine Carter, Moïse Roche, Paul Higgs, Zuzana Walker, et al.

    Objectives: Many people live with an awareness of mild cognitive changes that increase their dementia risk. Previous authors describe the uncertainties of this liminal state, between cognitive health and dementia, where being “at risk” can itself be an illness. We ask how services respond to people with memory concerns currently, and how a future, effective and inclusive dementia prevention intervention might be structured for people with memory concerns.Methods/Design: We conducted qualitative interviews with 18 people aged 60+ years with subjective or objective memory problems, six family members, 10 health and social care professionals and 11 third sector workers. Interviews were audio‐recorded, transcribed and analysed using an inductive thematic approach.Results: Three main themes were identified: (1) acknowledging the liminal state, compounded by current, discordant health service responses: medicalising memory concerns yet situating responsibilities for their management with patients and families; (2) enabling change in challenging contexts of physical and cognitive frailty and social disengagement and (3) building on existing values, cultures and routines.Conclusions: Effective dementia prevention must empower individuals to make lifestyle changes within challenging contexts. Programmes must be evidence based yet sufficiently flexible to allow new activities to be fitted into people's current lives; and mindful of the risks of pathologising memory concerns. Most current memory services are neither commissioned, financially or clinically resourced to support people with memory concerns without dementia. Effective, large scale dementia prevention will require a broad societal response.


  • APPLE‐Tree (Active Prevention in People at risk of dementia: Lifestyle, bEhaviour change and Technology to REducE cognitive and functional decline) programme: Protocol

    by Claudia Cooper, Elisa Aguirre, Julie A. Barber, Nick Bass, Henry Brodaty, Alexandra Burton, Paul Higgs, Rachael Hunter, Jonathan Huntley, Iain Lang, et al.

    Background: Observational studies indicate that approximately a third of dementia cases are attributable to modifiable cardiometabolic, physical and mental health, and social and lifestyle risk factors. There is evidence that intensive behaviour change interventions targeting these factors can reduce cognitive decline. Our planned intervention [Colour figure can be viewed at wileyonlinelibrary.com] image Methods and analysis: We will design and test a low intensity, secondary dementia‐prevention programme (Active Prevention in People at risk of dementia: Lifestyle, bEhaviour change and Technology to REducE cognitive and functional decline, “APPLE‐Tree”) to slow cognitive decline in people with subjective cognitive decline with or without objective cognitive impairment. We will embed our work within social science research to understand how dementia prevention is currently delivered and structured. We will carry out systematic reviews and around 50 qualitative interviews with stakeholders, using findings to coproduce the APPLE‐Tree intervention. We plan a 10‐session group intervention, involving personalised goal‐setting, with individual sessions for those unable or unwilling to attend groups, delivered by psychology assistants who will be trained and supervised by clinical psychologists. The coproduction group (including public and patient involvement [PPI], academic and clinical/third‐sector professional representatives) will use the Behaviour Change Wheel theoretical framework to develop it.We will recruit and randomly allocate 704 participants, 1:1 to the intervention: informational control group. This sample size is sufficient to detect a between‐group difference at 2 years of 0.15 on the primary outcome (cognition: modified neuropsychological test battery; 90% power, 5% significance, effect size 0.25, SD 0.6).Dissemination: We will work with Public Health England and third‐sector partners to produce an effective national implementation approach, so that if our intervention works, it is used in practice.


  • Open Access

    Investigating the relationship between age of onset of depressive disorder and cognitive function

    by Irem Ece Eraydin, Christoph Mueller, Anne Corbett, Clive Ballard, Helen Brooker, Keith Wesnes, Dag Aarsland, Jonathan Huntley

    Objectives: Depressive disorder is commonly associated with impaired cognitive function; however, it is unclear whether the age of onset of the first episode of depression, current depression severity, or historical severity of depressive episodes are associated with cognitive performance.Methods: This study examined baseline cross‐sectional data from the ongoing online PROTECT study. A total of 7344 participants, 50 years or older, with a history of depression and no diagnosis of dementia were divided into three groups according to age of onset of their first depressive episode: early‐onset, midlife‐onset, and late‐onset. Performance on measures of visuospatial episodic memory, executive function, verbal working, and visual working memory were evaluated. Demographic and clinical characteristics such as age, education, and severity of symptoms during their worst previous depressive episode and current depression severity were included in multivariate regression models.Results: The late‐onset depression group scored significantly lower on the verbal reasoning task than the early‐onset group while there were no significant differences found on the other tasks. Midlife‐onset depression participants performed better in the visual episodic memory task, but worse on the verbal reasoning task, than early‐onset depression participants. Current depression severity was negatively correlated with all four cognitive domains, while historical severity score was found to be significantly associated with cognitive performance on the verbal reasoning and spatial working memory tasks.Conclusions: The most important indicator of cognitive performance in depression appears to be current, rather than historic depression severity; however, late‐onset depression may be associated with more executive impairment than an early‐onset depression.